NASDAQ Composite ended the session with Amazon rising 1.58% to $3,188.10 on Thursday, following last session’s downward trend. NASDAQ Composite rose 2.61% to $13,073.47, following last session’s downward trend on what was an all-around positive trend exchanging session today.
Amazon today’s close was $3,188.10, 11.42% under its 52-week high of $3,552.25.
Amazon’s sales growth is 36.7% for the present quarter and 26.3% for the next. The company’s growth estimates for the current quarter and the next is 10.5% and 84%, respectively.
Year-on-year quarterly revenue growth grew by 37.4%, now sitting on 347.95B for the twelve trailing months.
Amazon’s last day, last week, and last month’s average volatility was a negative 2.55%, a negative 1.15%, and a negative 0.04%, respectively.
Amazon’s last day, last week, and last month’s high and low average amplitude percentage was 2.12%, 2.22%, and 2.02%, respectively.
Amazon’s Stock Yearly Top and Bottom Value
Amazon’s stock is valued at $3,188.10 at 16:10 EST, way under its 52-week high of $3,552.25 and way higher than its 52-week low of $1,626.03.
Amazon’s Moving Average
Amazon’s worth is higher than its 50-day moving average of $3,181.24 and above its 200-day moving average of $3,149.98.
Previous days news about Amazon
3 reasons why haven, Amazon’s joint healthcare venture with JPMorgan and Berkshire Hathaway, was doomed from the start. According to Business Insider on Monday, 4 January, “Just two months prior, Amazon added to Haven’s difficulties with the public launchof its own primary care service, Amazon Care.”, “Haven employees were shocked when they learned about Amazon Care through news reports in September 2019, according to The Information. “
A credit suisse rising star departs – what went wrong with Amazon’s haven – biden’s impact on red-hot IPO market. According to Business Insider on Tuesday, 5 January, “Haven, the health venture launched by Amazon with JPMorgan and Berkshire Hathaway is shutting down. “
According to Business Insider on Tuesday, 5 January, “Cloud services like Microsoft’s Azure or Amazon Web Services are seen as a safer alternative than hosting infrastructure locally, in part because they have better security monitoring and are regularly and automatically updated to patch vulnerabilities.”
Amazon is now selling an fda-approved at-home saliva Covid-19 test for $110. all you do is spit in a tube and send it to an LA lab via pre-paid shipping.. According to Business Insider on Wednesday, 6 January, “The test kit was authorized by the FDA on December 9, but was made available on Amazon on Tuesday.”, “The DxTerity COVID-19 Saliva at-Home Collection Kit is priced on Amazon at $110 for one, or $1,000 for 10.”